• Profile
Close

Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review

PLoS Neglected Tropical Diseases Dec 11, 2019

Tan QQ, et al. - Researchers assessed comparative studies comparing the refractive errors in children, birthweights ≤ 1500 grams and gestational ages ≤ 30 weeks, and treatments for Type I retinopathy of prematurity (ROP) with intravitreal bevacizumab (IVB) vs laser photocoagulation in order to ascertain development of refractive error in preterm children with severe ROP managed with anti-VEGF agents and laser photocoagulation. In this study, they included two randomized controlled trials and 5 non-randomized studies, that comprised a total of 272 eyes treated by IVB and 247 eyes treated by laser. Findings revealed an association of treatment with IVB with less myopia and astigmatism than laser treatment for infants with severe ROP. In view of the complexity of ROP and the variability of dosing, they suggest performing close monitoring of refractive error outcomes in children treated with IVB.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay